Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.34
+0.11 (1.03%)
At close: Feb 11, 2026, 4:00 PM EST
10.36
+0.02 (0.24%)
After-hours: Feb 11, 2026, 4:32 PM EST

Design Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5903491485731,183-
Market Cap Growth
105.98%135.41%-74.10%-51.55%--
Enterprise Value
38698-139233793-
Last Close Price
10.366.172.6510.2621.41-
PB Ratio
2.951.440.531.753.10-
P/TBV Ratio
2.951.440.531.753.10-
Debt / Equity Ratio
0.010.010.010.010.01-
Asset Turnover
-----0.01
Quick Ratio
18.5629.1629.4430.7672.7215.49
Current Ratio
18.7129.3129.5831.1072.9615.55
Return on Equity (ROE)
-29.83%-19.08%-22.10%-17.85%-17.08%-54.47%
Return on Assets (ROA)
-20.49%-14.39%-15.50%-11.55%-10.49%-28.44%
Return on Capital Employed (ROCE)
-38.70%-25.60%-27.90%-20.50%-9.30%-24.40%
Earnings Yield
-11.43%-14.19%-45.05%-11.05%-3.00%-
FCF Yield
-8.88%-12.44%-39.63%-9.12%-2.61%-
Buyback Yield / Dilution
-0.66%-1.08%-0.50%-21.27%-190.80%-2.08%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q